- $607.27m
- $370.18m
- $139.93m
- 74
- 30
- 11
- 32
Annual balance sheet for RxSight, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 69 | 159 | 106 | 127 | 237 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.87 | 4.86 | 11 | 20.3 | 30.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 81.5 | 176 | 135 | 168 | 294 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 18.6 | 15.5 | 14.1 | 13.3 | 23.6 |
| Other Long Term Assets | |||||
| Total Assets | 101 | 193 | 150 | 183 | 319 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.6 | 11.1 | 17.2 | 20.9 | 25.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 44.9 | 54.5 | 60.3 | 22.2 | 37.3 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 55.8 | 138 | 89.9 | 160 | 281 |
| Total Liabilities & Shareholders' Equity | 101 | 193 | 150 | 183 | 319 |
| Total Common Shares Outstanding |